Yes. Their stable resorption performance enables sensitive detection of inhibitory effects from candidate therapeutics. Researchers can reliably assess osteoclast suppression, pathway modulation, and functional changes using our reproducible, well-characterized cell lots.
We verify TRAP expression, multinucleation levels, bone-resorption activity, and viability. These markers confirm that cells exhibit authentic osteoclast physiology essential for bone-degradation studies.
We recommend medium supplemented with M-CSF and RANKL. These factors support phenotype stability, enabling predictable resorption behavior and long-term functional consistency.
For Research Use Only. Do Not Use in Food Manufacturing or Medical Procedures (Diagnostics or Therapeutics). Do Not Use in Humans.